↓ Skip to main content

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adj…

Overview of attention for article published in BMC Cancer, September 2018
Altmetric Badge

Citations

dimensions_citation
123 Dimensions

Readers on

mendeley
117 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Published in
BMC Cancer, September 2018
DOI 10.1186/s12885-018-4770-2
Pubmed ID
Authors

Astrid E. Slagter, Edwin P. M. Jansen, Hanneke W. M. van Laarhoven, Johanna W. van Sandick, Nicole C. T. van Grieken, Karolina Sikorska, Annemieke Cats, Pietje Muller-Timmermans, Maarten C. C. M. Hulshof, Henk Boot, Maartje Los, Laurens V. Beerepoot, Frank P. J. Peters, Geke A. P. Hospers, Boudewijn van Etten, Henk H. Hartgrink, Mark I. van Berge Henegouwen, Grard A. P. Nieuwenhuijzen, Richard van Hillegersberg, Donald L. van der Peet, Heike I. Grabsch, Marcel Verheij

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 117 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 117 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 15%
Student > Postgraduate 13 11%
Other 10 9%
Student > Ph. D. Student 10 9%
Student > Master 9 8%
Other 27 23%
Unknown 31 26%
Readers by discipline Count As %
Medicine and Dentistry 52 44%
Nursing and Health Professions 7 6%
Biochemistry, Genetics and Molecular Biology 5 4%
Unspecified 4 3%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 6 5%
Unknown 40 34%